These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 30148983)

  • 1. Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction.
    Calva CB; Fadel JR
    Brain Res; 2020 Mar; 1731():145921. PubMed ID: 30148983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Intranasal Orexin-A (Hypocretin-1) Administration on Neuronal Activation, Neurochemistry, and Attention in Aged Rats.
    Calva CB; Fayyaz H; Fadel JR
    Front Aging Neurosci; 2019; 11():362. PubMed ID: 32038222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased acetylcholine and glutamate efflux in the prefrontal cortex following intranasal orexin-A (hypocretin-1).
    Calva CB; Fayyaz H; Fadel JR
    J Neurochem; 2018 May; 145(3):232-244. PubMed ID: 29250792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orexin A-induced enhancement of attentional processing in rats: role of basal forebrain neurons.
    Zajo KN; Fadel JR; Burk JA
    Psychopharmacology (Berl); 2016 Feb; 233(4):639-47. PubMed ID: 26534765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocretin/orexin antagonism enhances sleep-related adenosine and GABA neurotransmission in rat basal forebrain.
    Vazquez-DeRose J; Schwartz MD; Nguyen AT; Warrier DR; Gulati S; Mathew TK; Neylan TC; Kilduff TS
    Brain Struct Funct; 2016 Mar; 221(2):923-40. PubMed ID: 25431268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron Emission Tomography Assessment of the Intranasal Delivery Route for Orexin A.
    Van de Bittner GC; Van de Bittner KC; Wey HY; Rowe W; Dharanipragada R; Ying X; Hurst W; Giovanni A; Alving K; Gupta A; Hoekman J; Hooker JM
    ACS Chem Neurosci; 2018 Feb; 9(2):358-368. PubMed ID: 29035509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal insulin and orexins to treat age-related cognitive decline.
    Erichsen JM; Calva CB; Reagan LP; Fadel JR
    Physiol Behav; 2021 May; 234():113370. PubMed ID: 33621561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aging-related deficits in orexin/hypocretin modulation of the septohippocampal cholinergic system.
    Stanley EM; Fadel J
    Synapse; 2012 May; 66(5):445-52. PubMed ID: 22213437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep, Orexin and Cognition.
    Toor B; Ray LB; Pozzobon A; Fogel SM
    Front Neurol Neurosci; 2021; 45():38-51. PubMed ID: 34052810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orexin-A facilitates emergence of the rat from isoflurane anesthesia via mediation of the basal forebrain.
    Zhang LN; Yang C; Ouyang PR; Zhang ZC; Ran MZ; Tong L; Dong HL; Liu Y
    Neuropeptides; 2016 Aug; 58():7-14. PubMed ID: 26919917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal post-cardiac arrest treatment with orexin-A facilitates arousal from coma and ameliorates neuroinflammation.
    Modi HR; Wang Q; Gd S; Sherman D; Greenwald E; Savonenko AV; Geocadin RG; Thakor NV
    PLoS One; 2017; 12(9):e0182707. PubMed ID: 28957432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The orexin story, sleep and sleep disturbances.
    Pizza F; Barateau L; Dauvilliers Y; Plazzi G
    J Sleep Res; 2022 Aug; 31(4):e13665. PubMed ID: 35698789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orexin/hypocretin treatment restores hippocampal-dependent memory in orexin-deficient mice.
    Mavanji V; Butterick TA; Duffy CM; Nixon JP; Billington CJ; Kotz CM
    Neurobiol Learn Mem; 2017 Dec; 146():21-30. PubMed ID: 29107703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep disorders, obesity, and aging: the role of orexin.
    Nixon JP; Mavanji V; Butterick TA; Billington CJ; Kotz CM; Teske JA
    Ageing Res Rev; 2015 Mar; 20():63-73. PubMed ID: 25462194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates.
    Deadwyler SA; Porrino L; Siegel JM; Hampson RE
    J Neurosci; 2007 Dec; 27(52):14239-47. PubMed ID: 18160631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous intrathecal orexin delivery inhibits cataplexy in a murine model of narcolepsy.
    Kaushik MK; Aritake K; Imanishi A; Kanbayashi T; Ichikawa T; Shimizu T; Urade Y; Yanagisawa M
    Proc Natl Acad Sci U S A; 2018 Jun; 115(23):6046-6051. PubMed ID: 29784823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging-related alterations in orexin/hypocretin modulation of septo-hippocampal amino acid neurotransmission.
    Stanley EM; Fadel JR
    Neuroscience; 2011 Nov; 195():70-9. PubMed ID: 21884758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal orexin A modulates sympathetic vascular tone: a pilot study in healthy male humans.
    Meusel M; Voß J; Krapalis A; Machleidt F; Vonthein R; Hallschmid M; Sayk F
    J Neurophysiol; 2022 Feb; 127(2):548-558. PubMed ID: 35044844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypocretin/Orexin Receptor Pharmacology and Sleep Phases.
    Sun Y; Tisdale RK; Kilduff TS
    Front Neurol Neurosci; 2021; 45():22-37. PubMed ID: 34052813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypocretin/orexin system: an increasingly important role in neuropsychiatry.
    Chen Q; de Lecea L; Hu Z; Gao D
    Med Res Rev; 2015 Jan; 35(1):152-97. PubMed ID: 25044006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.